News | April 08, 2025
Lyka Labs secures Indian patent for Pregabalin Gel 8%
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
Bloom has pioneered a technology to transform plant waste into valuable chemical products
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Announces Rs. 317 crore investment in new recycling plant
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
This rating reflects Lupin's leadership in environmental transparency and performance
Subscribe To Our Newsletter & Stay Updated
